mk-3118 and Pulmonary-Aspergillosis

mk-3118 has been researched along with Pulmonary-Aspergillosis* in 1 studies

Reviews

1 review(s) available for mk-3118 and Pulmonary-Aspergillosis

ArticleYear
Ibrexafungerp: First Approval.
    Drugs, 2021, Volume: 81, Issue:12

    Ibrexafungerp (BREXAFEMME

    Topics: Antifungal Agents; Candidiasis, Invasive; Candidiasis, Vulvovaginal; Female; Glycosides; Humans; Invasive Fungal Infections; Male; Pulmonary Aspergillosis; Triterpenes

2021